Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ADIR claims tachykinin antagonists

June 14, 1996

Dopamine D4 receptor ligands discovered by Pfizer

June 7, 1996

Clinical trials anticipated for CoCensys' and Ciba-Geigy's codeveloped EAA antagonist

June 7, 1996

Ciba-Geigy discloses glycine-site NMDA antagonists

June 7, 1996

BASF reports glutamate receptor antagonists

June 7, 1996

GR-205171: A non-peptide neurokinin NK1 antagonist

June 7, 1996

ADIR reports piperazines with affinity for sigma-receptors

June 7, 1996

Botulinum toxin type A: Treatment of choice for idiopathic cervical dystonia

June 7, 1996

Connective Therapeutics' peptide vaccine trial results presented

June 7, 1996

CellPro and Northwestern University commence first BMT clinical trial in MS patients

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...